PKU Skin Stripping
NCT04368624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 86
Last updated 2021-07-28
Summary
PURPOSE OF STUDY: To determine if a non-invasive skin stripping technique can be used to detect individuals with phenylalanine abnormalities, and to monitor dietary and/or drug effects over time.
Conditions
- Phenylketonurias
Interventions
- OTHER
-
Skin Tape
Skin sample collection: samples of human stratum corneum will be obtained with squame adhesive tape disks typically at the time of their clinic appointment. The tape will be placed on the inside of the forearm and the procedure will be repeated up to five times per patient to have sufficient corneocytes for analysis. This type of sampling is non-invasive.
- DIAGNOSTIC_TEST
-
Blood Draw
Blood specimens: blood will be obtained for serum amino acids/phenylalanine levels. This sample is obtained for disease monitoring as part of routine standard of care. Results from up to three clinic visits will be correlated with the tape sample obtained on the same day.
Sponsors & Collaborators
- collaborator INDUSTRY
-
Children's Hospital Medical Center, Cincinnati
lead OTHER
Principal Investigators
-
Carlos E Prada, MD · Children's Hospital Medical Center, Cincinnati
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-10-12
- Primary Completion
- 2020-12-31
- Completion
- 2021-04-30
Countries
- United States
Study Locations
More Related Trials
-
A Phase 3, Multicenter, Open-Label Extension Study of Phenoptin in Subjects With PKU Who Have Elevated Phenylalanine Levels
NCT00225615 ·Status: COMPLETED ·Phase: PHASE3
-
Kuvan Therapy in Phenylketonuria (PKU): The Effect of Blood Phenylalanine Concentration on Kuvan Response
NCT00841100 ·Status: COMPLETED ·Phase: PHASE2
-
Testing of Four Home Phenylalanine Monitoring Prototype Devices
NCT02445521 ·Status: COMPLETED
-
Study to Evaluate the Safety and Efficacy of Pegvaliase in Adolescents (Ages 12-17) With Phenylketonuria
NCT05270837 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)
NCT00924703 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CDX 6114 in PKU Patients
NCT04256655 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety, Tolerability, and Efficacy Study of rAvPAL-PEG Administered Daily in Subjects With Phenylketonuria (PKU)
NCT01212744 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 3 Study to Evaluate the Efficacy & Safety of Self-Administered Injections of BMN165 by Adults With PKU
NCT01889862 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Effects of Kuvan on Individuals With Phenylketonuria (PKU) With Maladaptive Behaviors
NCT00728676 ·Status: COMPLETED
-
Biological Variation of Phenylalanine in Patients With Hyperphenylalaninemia
NCT01869972 ·Status: COMPLETED
-
Nutrition Status of Adults With PKU Before and During Treatment With Pegvaliase
NCT03856203 ·Status: COMPLETED
-
Antioxidant Signature in Adult Patients With Phenylketonuria
NCT02212288 ·Status: COMPLETED
-
Simple Breath Test to Examine Phenylalanine Metabolism
NCT02009904 ·Status: COMPLETED
-
Effects of Synergy on Nutrient Intake and Acceptability in Phenylketonuria (PKU)
NCT03777826 ·Status: COMPLETED ·Phase: NA
-
Study of Phenoptin in Subjects With Phenylketonuria Who Participated in Protocols PKU-004 or PKU-006
NCT00332189 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-Interventional Interview Study of Phenylketonuria (PKU) Adults
NCT03505125 ·Status: COMPLETED
-
Natural History Clinical Study in Adult PKU
NCT04768348 ·Status: TERMINATED
-
Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of CDX-6114 in Patients With Phenylketonuria (PKU)
NCT04085666 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With Phenylketonuria
NCT00104260 ·Status: COMPLETED ·Phase: PHASE2
-
Phenylketonuria, Oxidative Stress, and BH4
NCT01395394 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Tolerability of RTX-134 in Adults With Phenylketonuria
NCT04110496 ·Status: TERMINATED ·Phase: PHASE1
-
Study to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine Levels
NCT00104247 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Phenylalanine Elevations on Brain and Cognition in Adult PKU Carriers
NCT07220265 ·Status: RECRUITING ·Phase: NA
-
Study of Phenoptin to Increase Phenylalanine Tolerance in Phenylketonuric Children on a Phenylalanine-restricted Diet
NCT00272792 ·Status: COMPLETED ·Phase: PHASE3
-
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
NCT02437396 ·Status: RECRUITING